Consortium Consortium



Click here to download
the flyer

Rationale & Design Paper Rationale & Design Paper
Background Background
The Project The Project
Impact Impact

Login Login


The Group - Consortium - University of HULL

University of HULL
HU16 5JQ

United Kingdom

Project Leader

Prof. John Cleland Prof. John Cleland
Project Leader 
Phone: +44 (0)1482 461 776 
Fax: +44 (0)1482 461 779 
E-Mail to Prof. John Cleland Contact  

Project Staff

John Warden John Warden
Project Manager and Data Manager for WP03 
Phone: +44 (0)1482 461917 

Amanda Crundall Amanda Crundall
Lead HF Nurse 

Dr. Pierpaolo Pellicori Dr. Pierpaolo Pellicori
Lead Medic 

Sarah Jane Smith Sarah Jane Smith
Research Nurse 

Anna Bennett Anna Bennett
Echo and DEXA Technician 

Stella Rimmer Stella Rimmer
Clinic Support Worker 

Institute Presentation

Founded in 1927, the University of Hull is the 14th oldest university in England. It has a strong tradition in both the Arts and Sciences and is home to over 20,000 students and 2,500 staff, offering some 2,200 courses. The National Students Survey has consistently ranked the University in the top 10 in England. The University has a strong reputation for research, including the initial development of Liquid Crystal technology.

One of the University’s most renowned members of staff was the poet Philip Larkin, who was Librarian for 30 years and wrote some of his best work while at Hull. Other famous alumni include film director Anthony Minghella, poet Roger McGough , former Deputy Prime Minister John (now Lord) Prescott and Beirut hostage John McCarthy.

In conjunction with the University of York it is home to the Hull York Medical School and also hosts the Post Graduate Medical Institute. Within the PGMI the Department of Academic Cardiology under Professor John G F Cleland has established a world-wide reputation for leading-edge research into heart failure. Based in the recently constructed Daisy Building at Castle Hill Hospital, the Department is one of the leading cardiac research centres in the world and is an international reference centre for the management of heart failure. It has the largest clinical programme for heart failure in Britain. The programme allows the development of new techniques for earlier and more accurate diagnosis, better risk assessment and for delivering the highest quality modern therapy.
With ten consultant cardiologists, fourteen other doctors, ten researchers and sixteen nursing staff the Department of Academic Cardiology has seen several major developments in recent years. The most important recent success was developing a new type of pacemaker that can help about one in five people who have had major heart damage from heart attacks or other muscle disease (cardiomyopathy). By placing an extra electrical lead in the heart, the strength of the heart can be improved substantially in many patients and, for some, even appears to cure their heart failure. The pacemaker not only improves heart function but also improves symptoms of breathlessness and reduces the risk of dying, either of heart failure or dying suddenly. The benefits are much larger than for most operations or procedures. This study is thought by many to be the finest piece of research in this area world-wide.
The Department is also the home of the European Journal of Heart Failure editorial office.

University of HULL